Malin Corporation | MLC - Aktuelle Verpflichtungen

Aktienkurs
7.95
Täglich Wechseln
0 0%
Monatlich
3.25%
Jährlich
-6.47%
Q2 Prognose
7.71




Aktuelle Verpflichtungen Veränderung Datum
Akebia Therapeutics USD 162.94M 29.56M 2025-12
Alaunos Therapeutics USD 921K 153K 2025-09
ALKERMES USD 543.44M 69.08M 2025-12
Avita Medical AUD 62.68M 77K 2025-12
Dianthus Therapeutics USD 30.73M 6.88M 2025-12
Eurofins Scientific SE EUR 2.43B 344.6M 2025-12
Ionis Pharmaceuticals USD 783M 120.46M 2025-12
IQVIA Holdings USD 8.34B 170M 2025-12
Lonza CHF 3.57B 421M 2025-12
Malin Corporation EUR 1000K 500K 2024-12
Moderna USD 1.99B 306M 2025-12
Organon & Co USD 2.68B 117M 2025-09
Ovoca Bio EUR 186K 2.26M 2025-06
Revvity USD 1.33B 108.5M 2025-12
Tectonic Therapeutic USD 9.67M 293K 2025-12
Viatris USD 7.09B 269.8M 2025-12
Xeris Pharmaceuticals USD 109.57M 6.63M 2025-12